Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA94762
Max Phase: Preclinical
Molecular Formula: C39H55N7O5
Molecular Weight: 701.91
Molecule Type: Small molecule
Associated Items:
ID: ALA94762
Max Phase: Preclinical
Molecular Formula: C39H55N7O5
Molecular Weight: 701.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC1CCN(C(=O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CCc2ccccn2)CC1
Standard InChI: InChI=1S/C39H55N7O5/c40-30-16-19-46(20-17-30)36(48)23-29(21-27-9-3-1-4-10-27)38(50)45-34(24-32-25-41-26-43-32)39(51)44-33(22-28-11-5-2-6-12-28)37(49)35(47)15-14-31-13-7-8-18-42-31/h1,3-4,7-10,13,18,25-26,28-30,33-35,37,47,49H,2,5-6,11-12,14-17,19-24,40H2,(H,41,43)(H,44,51)(H,45,50)/t29-,33+,34+,35+,37-/m1/s1
Standard InChI Key: LGVOTNOMAMGKRU-XHRNTERESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 701.91 | Molecular Weight (Monoisotopic): 701.4265 | AlogP: 2.84 | #Rotatable Bonds: 17 |
Polar Surface Area: 186.56 | Molecular Species: BASE | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.41 | CX Basic pKa: 9.98 | CX LogP: 1.42 | CX LogD: -1.09 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.12 | Np Likeness Score: -0.04 |
1. Heitsch H, Henning R, Kleemann HW, Linz W, Nickel WU, Ruppert D, Urbach H, Wagner A.. (1993) Renin inhibitors containing a pyridyl amino diol derived C-terminus., 36 (19): [PMID:8410992] [10.1021/jm00071a009] |
2. Ramya K, Suresh R, Kumar HY, Kumar BRP, Murthy NBS.. (2020) Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules., 28 (10): [PMID:32247750] [10.1016/j.bmc.2020.115466] |
Source(1):